logo
Share SHARE
FONT-SIZE Plus   Neg

KineMed And Pfizer Extend Collaboration On Type II Diabetes - Quick Facts

KineMed Inc. announced the renewal of a non-exclusive research collaboration with Pfizer Inc. (PFE) for the advancement of novel approaches in metabolic disease, in particular Type II diabetes.

KineMed stated that the collaboration employs its novel dynamic proteomics technology platform to map the impact of potential drug candidates on specific metabolic pathways.

"This platform has been useful in accelerating advancement and de-risking compounds in Type II diabetes. We look forward to continuing our work with Pfizer on their compounds in preclinical and clinical trials," said Marc Hellerstein, President, Chief Science Officer and Co-founder at KineMed.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Sporting goods retailer Dick's Sporting Goods, Inc. has emerged as the successful bidder in the bankruptcy auction for its former rival Sports Authority Holding Inc.'s intellectual property assets and the right to acquire 31 store leases. Swedish music streaming app Spotify says that Apple has rejected an update of its iOS app. One of the top marketing executives of Chipotle Mexican Grill Inc., Mark Crumpacker, was put on administrative leave after he was indicted as part of a cocaine drug ring bust in New York. Crumpacker, Chipotle's chief creative and development officer, is reportedly one of the eighteen alleged buyers of cocaine indicted in the drug ring.
comments powered by Disqus
Follow RTT